17 Capital Partners’s Merck MRK Stock Holding History

17 Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$927K	Buy	7,704 +100	+1%	+$11.5K	0.48%	75
2025 Q4	$800K	Sell	7,604 -31	-0.4%	-$2.91K	0.41%	85
2025 Q3	$641K	Hold	7,635	–	–	0.35%	92
2025 Q2	$604K	Buy	7,635 +930	+14%	+$73.9K	0.35%	91
2025 Q1	$602K	Sell	6,705 -5,788	-46%	-$540K	0.39%	82
2024 Q4	$1.24M	Sell	12,493 -292	-2%	-$30.1K	0.79%	42
2024 Q3	$1.45M	Sell	12,785 -825	-6%	-$98K	0.94%	30
2024 Q2	$1.68M	Buy	13,610 +308	+2%	+$39.7K	1.2%	17
2024 Q1	$1.76M	Hold	13,302	–	–	1.3%	16
2023 Q4	$1.45M	Buy	+13,302	New	+$1.38M	1.33%	23

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

17 Capital Partners's MRK Position: Q1 2026 in Review

17 Capital Partners increased its Merck (MRK) stake by 1.3% in Q1 2026, buying an estimated $11.5K and bringing the position to 7,704 shares worth $927K. The position accounts for 0.48% of the portfolio, ranked #75.

17 Capital Partners first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.76M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

17 Capital Partners held 7,704 shares of Merck worth $927K as of Q1 2026.
17 Capital Partners bought 100 Merck shares in Q1 2026, an estimated $11.5K.
Merck made up 0.48% of 17 Capital Partners's portfolio in Q1 2026, its #75 holding.
17 Capital Partners first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
17 Capital Partners's Merck position peaked at $1.76M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on 17 Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.